News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CSL.
RELATED STOCKHEAD STORIES
News
ASX Large Caps: Shares up four days in a row, Qantas chair quits, and BOQ sinks as profit tumbles
News
CSL, Pro Medicus, Goodman Group. Which other ASX stocks have brokers upgraded?
News
ASX Large Caps: ASX falls 1.28pc to hit 100-day low, RBA keeps rates on hold for now
News
Closing Bell: Bleak benchmark goes back to the beginning as Wall Street worries widen; RBA holds at 4.1pc
News
ASX Small Caps Lunch Wrap: Who’s just dying to make a bit of spare cash this week?
News
ASX Small Caps Lunch Wrap: Which US city is up in arms about a giant butthole this week?
Health & Biotech
ScoPo’s Powerplays: Who remembers that time they died? Oh, and Ramsay Healthcare cops credit downgrade
News
ASX Large Caps: RBA leaves rates on hold, Joyce to leave Qantas earlier, and Chalice takes more pounding
Health & Biotech
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as big names ‘trading at very attractive fundamentals’
Health & Biotech
ScoPo’s Powerplays: CSL leads ASX health stocks down is reporting season; ‘we weren’t expecting that’
Health & Biotech
ScoPo’s Powerplays: CSL, Cochlear drag ASX health sector up in mixed start to reporting season
News
CLOSING BELL: ASX eases to +0.39pc, led to greener pastures by a surging Health Care market
News
ASX Large Caps: Local bourse up as China cuts key rate; aftermarket stock GUD top gainer, up by 15pc
News
ASX Small Caps Lunch Wrap: Are bulletproof aliens really stealing Peruvian gold this week?
News
ASX Earnings Wrap: Reckon jumps 13pc; Pro Medicus keeps delivering, up almost 40pc this year
Health & Biotech